
    
      All the patients (patient group and control) will be included in the study after giving their
      consent. The clinical, biological and electrophysiological data concerning the neuropathy
      will be collected. There is no specific follow-up for the study.

      Blood samples will be retrospectively analyzed for antibody screening.
    
  